Meta Biomed Co., Ltd.

KOSDAQ:A059210 Voorraadrapport

Marktkapitalisatie: ₩94.1b

Meta Biomed Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Meta Biomed has a total shareholder equity of ₩82.6B and total debt of ₩56.5B, which brings its debt-to-equity ratio to 68.4%. Its total assets and total liabilities are ₩167.9B and ₩85.3B respectively. Meta Biomed's EBIT is ₩12.4B making its interest coverage ratio 5.1. It has cash and short-term investments of ₩45.3B.

Belangrijke informatie

68.4%

Verhouding schuld/eigen vermogen

₩56.48b

Schuld

Rente dekkingsratio5.1x
Contant₩45.35b
Aandelen₩82.57b
Totaal verplichtingen₩85.30b
Totaal activa₩167.87b

Recente financiële gezondheidsupdates

Recent updates

Earnings Tell The Story For Meta Biomed Co., Ltd. (KOSDAQ:059210) As Its Stock Soars 30%

Feb 26
Earnings Tell The Story For Meta Biomed Co., Ltd. (KOSDAQ:059210) As Its Stock Soars 30%

Here's How We Evaluate Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Dividend

Apr 11
Here's How We Evaluate Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Dividend

Meta Biomed's (KOSDAQ:059210) Stock Price Has Reduced 58% In The Past Five Years

Mar 14
Meta Biomed's (KOSDAQ:059210) Stock Price Has Reduced 58% In The Past Five Years

Are Meta Biomed's (KOSDAQ:059210) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 21
Are Meta Biomed's (KOSDAQ:059210) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Can Meta Biomed (KOSDAQ:059210) Continue To Grow Its Returns On Capital?

Feb 03
Can Meta Biomed (KOSDAQ:059210) Continue To Grow Its Returns On Capital?

Is Meta Biomed (KOSDAQ:059210) A Risky Investment?

Jan 13
Is Meta Biomed (KOSDAQ:059210) A Risky Investment?

Here's Why I Think Meta Biomed (KOSDAQ:059210) Is An Interesting Stock

Dec 26
Here's Why I Think Meta Biomed (KOSDAQ:059210) Is An Interesting Stock

Meta Biomed (KOSDAQ:059210) Share Prices Have Dropped 22% In The Last Five Years

Dec 08
Meta Biomed (KOSDAQ:059210) Share Prices Have Dropped 22% In The Last Five Years

Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Nov 20
Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Analyse van de financiële positie

Kortlopende schulden: A059210's short term assets (₩81.0B) exceed its short term liabilities (₩71.7B).

Langlopende schulden: A059210's short term assets (₩81.0B) exceed its long term liabilities (₩13.6B).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: A059210's net debt to equity ratio (13.5%) is considered satisfactory.

Schuld verminderen: A059210's debt to equity ratio has reduced from 71.4% to 68.4% over the past 5 years.

Schuldendekking: A059210's debt is well covered by operating cash flow (33.6%).

Rentedekking: A059210's interest payments on its debt are well covered by EBIT (5.1x coverage).


Balans


Ontdek gezonde bedrijven